Important Safety Information: CAPRELSA® (vandetanib) Tablets can cause a change in the electrical activity of your heart called QT prolongation, which can cause irregular heartbeats and that may lead to death. You should not take CAPRELSA if you have had a condition called long QT syndrome since birth. View more.
Sanofi Genzyme respects individual privacy and values the confidence of its customers, partners, patients and employees.
You are leaving caprelsa.com, a website of Genzyme Corporation. Genzyme Corporation does not review or control the content of non-Genzyme websites, and this hyperlink does not constitute an endorsement by Genzyme of the site’s content. Genzyme’s privacy procedures do not apply to the owners of a non-Genzyme website.